[go: up one dir, main page]

AU2001291233A1 - Polymorphs of pioglitazone hydrochloride and their use as antidiabetics - Google Patents

Polymorphs of pioglitazone hydrochloride and their use as antidiabetics

Info

Publication number
AU2001291233A1
AU2001291233A1 AU2001291233A AU9123301A AU2001291233A1 AU 2001291233 A1 AU2001291233 A1 AU 2001291233A1 AU 2001291233 A AU2001291233 A AU 2001291233A AU 9123301 A AU9123301 A AU 9123301A AU 2001291233 A1 AU2001291233 A1 AU 2001291233A1
Authority
AU
Australia
Prior art keywords
antidiabetics
polymorphs
pioglitazone hydrochloride
pioglitazone
hydrochloride
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001291233A
Inventor
Om Reddy Gaddam
Ramabhadra Sarma Mamillapalli
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Dr Reddys Research Foundation
Original Assignee
Dr Reddys Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dr Reddys Research Foundation filed Critical Dr Reddys Research Foundation
Publication of AU2001291233A1 publication Critical patent/AU2001291233A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2001291233A 2000-10-05 2001-09-25 Polymorphs of pioglitazone hydrochloride and their use as antidiabetics Abandoned AU2001291233A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN845MA2000 2000-10-05
IN845/MAS/00 2000-10-05
PCT/US2001/029899 WO2002028857A1 (en) 2000-10-05 2001-09-25 Polymorphs of pioglitazone hydrochloride and their use as antidiabetics

Publications (1)

Publication Number Publication Date
AU2001291233A1 true AU2001291233A1 (en) 2002-04-15

Family

ID=11097189

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001291233A Abandoned AU2001291233A1 (en) 2000-10-05 2001-09-25 Polymorphs of pioglitazone hydrochloride and their use as antidiabetics

Country Status (2)

Country Link
AU (1) AU2001291233A1 (en)
WO (1) WO2002028857A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7041691B1 (en) 1999-06-30 2006-05-09 Amgen Inc. Compounds for the modulation of PPARγ activity
US20030171399A1 (en) 2000-06-28 2003-09-11 Tularik Inc. Quinolinyl and benzothiazolyl modulators
WO2003026586A2 (en) * 2001-09-28 2003-04-03 Teva Pharmaceutical Industries Ltd. Pioglitazone hydrochloride
EP1388352A1 (en) * 2002-08-08 2004-02-11 Laboratoires Fournier S.A. Use of a ppar-alpha agonist to treat patients suffering from weight gain associated with a ppar-gamma agonist treatment
WO2005021542A2 (en) * 2003-08-28 2005-03-10 Ranbaxy Laboratories Limited Process for the preparation of pioglitazone
US7223761B2 (en) 2003-10-03 2007-05-29 Amgen Inc. Salts and polymorphs of a potent antidiabetic compound
US20100222334A1 (en) * 2007-10-09 2010-09-02 Wayne Talamonti Pharmaceutical Formulation of Valsartan

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IN182496B (en) * 1996-02-20 1999-04-17 Reddy Research Foundation
US5952509A (en) * 1996-06-27 1999-09-14 Takeda Chemical Industries, Ltd. Production of benzaldehyde compounds

Also Published As

Publication number Publication date
WO2002028857A1 (en) 2002-04-11
WO2002028857A8 (en) 2002-09-06

Similar Documents

Publication Publication Date Title
AU2002330943A1 (en) Immunomodulatory compounds and methods of use thereof
AU2001277741A1 (en) 2-aminopyridine compounds and use thereof as drugs
AU2000260550A1 (en) Treatment of skin damage using polyenylphosphatidylcholine
AU2001269046A1 (en) Use of therapeutic benzamide derivatives
AU2002226486A1 (en) Novel c-glycoside derivatives and use thereof
AU2001244355A1 (en) Heterobiarylsulphonamides and their use as pde 7 inhibitors
AU2001287898A1 (en) Pyrazolopyridines and pyrazolopyridazines as antidiabetics
AU2002335085A1 (en) Angiopoietins and methods of use thereof
AU2002225954A1 (en) Dipeptidylpeptidases and methods of use
AU2002226487A1 (en) Novel c-glycoside derivatives and use thereof
AU2002314466A1 (en) Withasol and methods of use
AU2001255199A1 (en) Ceramide derivatives and method of use
AU2001281850A1 (en) Use of inulin and inulin derivatives
AU2001281140A1 (en) Anti-plasmodium compositions and methods of use
AU2001216218A1 (en) Heterocyclic analgesic compounds and method of use thereof
AU2001269314A1 (en) Therapeutic and prophylactic use of reduced forms of pharmaceutical compounds
AU2002306624A1 (en) Heterocyclic analgesic compounds and methods of use thereof
AU2002213346A1 (en) Osteopontin-coated surfaces and methods of use
AU2002308891A1 (en) Novel heterocyclic derivatives and medicinal use thereof
AU2001273052A1 (en) Antifungal compounds and methods of use
AU2001227084A1 (en) N-arylhydrazide compounds and use thereof as drugs
AU2001291233A1 (en) Polymorphs of pioglitazone hydrochloride and their use as antidiabetics
AU2002308889A1 (en) Novel heterocyclic compound and medicinal use thereof
AU2962400A (en) Cleaner composition and method of use thereof
AU2001274022A1 (en) Use of substituted 1-amino-5-phenylpentane-3-ol and/or 1-amino-6-phenylhexane-3-ol compounds as medicaments